Suchergebnisse
10
Alles
Such-Filter
Organisationen
aTyr Pharma, Inc.
aTyr Pharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
27. März 2025 16:00 ET
|
aTyr Pharma, Inc.
aTyr Pharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
aTyr Pharma Announces the Appointment of Dalia R. Rayes as Head of Commercial, Global Efzofitimod Franchise
26. März 2025 08:00 ET
|
aTyr Pharma, Inc.
aTyr Pharma Announces the Appointment of Dalia R. Rayes as Head of Commercial, Global Efzofitimod Franchise
aTyr Pharma Announces Fourth Quarter and Full Year 2024 Results and Provides Corporate Update
13. März 2025 16:01 ET
|
aTyr Pharma, Inc.
aTyr Pharma Announces Fourth Quarter and Full Year 2024 Results and Provides Corporate Update
aTyr Pharma Announces Publication Demonstrating Efzofitimod’s Immunomodulatory Activity in Science Translational Medicine
12. März 2025 16:00 ET
|
aTyr Pharma, Inc.
aTyr Pharma Announces Publication Demonstrating Efzofitimod’s Immunomodulatory Activity in Science Translational Medicine
aTyr Pharma Announces Fourth Positive DSMB Review for Efzofitimod in Phase 3 EFZO-FIT™ Study in Pulmonary Sarcoidosis
06. März 2025 16:02 ET
|
aTyr Pharma, Inc.
aTyr Pharma Announces Fourth Positive DSMB Review for Efzofitimod in Phase 3 EFZO-FIT™ Study in Pulmonary Sarcoidosis
aTyr Pharma to Webcast Conference Call Reporting Fourth Quarter and Full Year End 2024 Financial Results
04. März 2025 08:00 ET
|
aTyr Pharma, Inc.
aTyr Pharma to Webcast Conference Call Reporting Fourth Quarter and Full Year End 2024 Financial Results
aTyr Pharma to Present at the Leerink Partners Global Healthcare Conference
24. Februar 2025 08:00 ET
|
aTyr Pharma, Inc.
aTyr Pharma to Present at the Leerink Partners Global Healthcare Conference
aTyr Pharma to Present Three Posters for Efzofitimod at the American Thoracic Society (ATS) 2025 International Conference
29. Januar 2025 08:00 ET
|
aTyr Pharma, Inc.
Blinded baseline demographics and disease characteristics for ongoing Phase 3 EFZO-FIT™ study of efzofitimod in pulmonary sarcoidosis; topline data from the study expected in the third quarter of 2025...
aTyr Pharma to Present at the 43rd Annual J.P. Morgan Healthcare Conference
17. Dezember 2024 08:00 ET
|
aTyr Pharma, Inc.
aTyr Pharma to Present at the 43rd Annual J.P. Morgan Healthcare Conference
aTyr Pharma Announces the Appointment of Eric Benevich to its Board of Directors
12. Dezember 2024 16:00 ET
|
aTyr Pharma, Inc.
aTyr Pharma Announces the Appointment of Eric Benevich to its Board of Directors